RNS Number:0254K
ReGen Therapeutics PLC
14 April 2003

ReGen Therapeutics Plc
14 April 2003

Immediate Release



                             ReGen Therapeutics Plc


                            SUBSTANTIAL SHAREHOLDING



London, UK - 14 April, 2003: ReGen Therapeutics Plc (the "Company") announces
that on 14 April 2003 it received notification from Hoodless Brennan & Partners
Plc ("Hoodless") that, following an acquisition by Hoodless of 32,793,333
ordinary shares of the Company on 10 April 2003, Hoodless's shareholding in the
Company was 23.27% of the issued share capital of the Company.



Further, the Company received notification from Hoodless on 14 April 2003 that,
following a disposal by it of 12,581,666 ordinary shares of the Company on 10
April 2003, and a further disposal of 20,055,500 ordinary shares of the Company
on 11 April 2003, its shareholding is now less than 3% of the issued share
capital of the Company.





For further information, please contact:



Andrew Marshall            Tel. 020 7489 2033
Marshall Robinson Roe




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

HOLEAKLLFDFDEFE